Clinical Trial Update: Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research [EARLY_Phase 1]

View source ↗

Summary

This clinical trial from Zhejiang University is evaluating the safety and potential efficacy of Meta10-19 metabolically armed CD19 CAR-T cells in relapsed/refra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Meta10-19 metabolically armed CD19 CAR-T cells

Snippet

Sponsor: Zhejiang University | Conditions: Non-hodgkin Lymphoma,B Cell | EARLY_Phase 1 | Status: RECRUITING